Blonanserin 8mg Tablet PCD Franchise in Mumbai

Antipsychotic Medicine Supplier in Delhi

Schizophrenia & Psychiatry Tablet Distributor in Chennai

Mental Health Pharma Franchise in Pune

Blonanserin 8mg Stockist in Kolkata
Psychiatric Medicine Export & Manufacturing in Hyderabad

Home/Products /blonanserin-8-mg-tablet

Blorin 8 Tablet

Composition : Blonanserin (8mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Blorin 8 Tablet contains Blonanserin 8mg, an atypical antipsychotic indicated for schizophrenia and other psychotic disorders. It acts on dopamine and serotonin receptors to help stabilize mood, control hallucinations, and reduce delusions.

Belonging to the psychiatry and neurology segment, Blorin 8 Tablet is widely prescribed in psychiatric clinics, hospitals, and mental health centers. Its higher dose formulation provides flexibility in managing moderate to severe cases with optimized therapeutic effect.

Blonanserin is valued for its favorable safety and tolerability profile, making it easier for patients to adhere to long-term treatment plans. This contributes to consistent symptom control and improved quality of life.

For PCD pharma franchise partners, distributors, exporters, and third-party manufacturers, Blorin 8 Tablet offers a high-demand B2B opportunity. Its essential role in psychiatric treatment ensures strong repeat prescriptions and a stable market across India.


Read More

About the Product

Blorin 8 Tablet contains Blonanserin 8mg, an atypical antipsychotic indicated for schizophrenia and other psychotic disorders. It acts on dopamine and serotonin receptors to help stabilize mood, control hallucinations, and reduce delusions.

Belonging to the psychiatry and neurology segment, Blorin 8 Tablet is widely prescribed in psychiatric clinics, hospitals, and mental health centers. Its higher dose formulation provides flexibility in managing moderate to severe cases with optimized therapeutic effect.

Blonanserin is valued for its favorable safety and tolerability profile, making it easier for patients to adhere to long-term treatment plans. This contributes to consistent symptom control and improved quality of life.

For PCD pharma franchise partners, distributors, exporters, and third-party manufacturers, Blorin 8 Tablet offers a high-demand B2B opportunity. Its essential role in psychiatric treatment ensures strong repeat prescriptions and a stable market across India.


Common side effects include drowsiness, dizziness, weight gain, dry mouth, and mild gastrointestinal discomfort. Rare but serious side effects may include severe extrapyramidal symptoms, neuroleptic malignant syndrome, or cardiac arrhythmias. Seek immediate medical attention if severe stiffness, high fever, or irregular heartbeat occurs.

Blorin 8 Tablet is indicated for the treatment of schizophrenia and related psychotic disorders. It helps reduce hallucinations, delusions, agitation, and behavioral disturbances, supporting overall mental stability.

Take Blorin 8 Tablet exactly as prescribed. Do not stop the medication abruptly, as this may worsen symptoms. Inform your doctor if you have a history of heart disease, seizures, diabetes, or low blood pressure. Regular monitoring of side effects and therapeutic response is recommended.

Store Blorin 8 Tablet in a cool, dry place below 25°C, away from sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation